PACS Group, Inc. (NYSE:PACS) Receives Consensus Rating of “Moderate Buy” from Analysts

PACS Group, Inc. (NYSE:PACSGet Free Report) has received an average rating of “Moderate Buy” from the eight research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $34.00.

Several analysts have issued reports on the stock. Truist Financial decreased their price objective on shares of PACS Group from $46.00 to $32.00 and set a “buy” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. restated a “neutral” rating and set a $18.00 price objective on shares of PACS Group in a report on Tuesday, December 17th. Macquarie reduced their target price on PACS Group from $42.00 to $24.00 and set an “outperform” rating on the stock in a research note on Monday, January 6th. Finally, Stephens lowered their target price on shares of PACS Group from $48.00 to $31.00 and set an “overweight” rating for the company in a research note on Monday, November 18th.

View Our Latest Stock Analysis on PACS

PACS Group Trading Down 0.7 %

Shares of PACS opened at $14.09 on Wednesday. PACS Group has a twelve month low of $12.54 and a twelve month high of $43.92. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.71 and a quick ratio of 1.71. The company’s fifty day simple moving average is $13.97 and its 200-day simple moving average is $27.43.

Hedge Funds Weigh In On PACS Group

Institutional investors have recently made changes to their positions in the company. Wellington Management Group LLP lifted its stake in PACS Group by 60.5% in the third quarter. Wellington Management Group LLP now owns 5,376,551 shares of the company’s stock worth $214,901,000 after acquiring an additional 2,025,835 shares during the period. Zimmer Partners LP lifted its position in shares of PACS Group by 191.2% in the 3rd quarter. Zimmer Partners LP now owns 2,329,529 shares of the company’s stock worth $93,111,000 after purchasing an additional 1,529,529 shares during the period. FMR LLC boosted its stake in shares of PACS Group by 174.4% during the third quarter. FMR LLC now owns 1,641,651 shares of the company’s stock valued at $65,617,000 after purchasing an additional 1,043,399 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in PACS Group by 5.9% during the third quarter. JPMorgan Chase & Co. now owns 1,272,720 shares of the company’s stock valued at $50,871,000 after buying an additional 70,786 shares during the period. Finally, Crewe Advisors LLC raised its stake in PACS Group by 66,972.9% in the fourth quarter. Crewe Advisors LLC now owns 1,112,068 shares of the company’s stock worth $14,579,000 after buying an additional 1,110,410 shares in the last quarter.

PACS Group Company Profile

(Get Free Report

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Featured Stories

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.